|Podcasts|March 11, 2022
Pharmacy Focus: Psychedelic Pharmacy - Episode 5
Kelsey Ramsden, co-founder, president, and CEO at MindCure, discussed the potential links between sexual trauma and hypoactive sexual desire disorder in women.
Advertisement
In part 2 of the discussion with Kelsey Ramsden, co-founder, president, and CEO at MindCure, Ramsden discussed the potential links between sexual trauma and hypoactive sexual desire disorder in women. She also discussed how MDMA-assisted psychotherapy could help treat the disorder.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Daratumumab and Hyaluronidase-fihj With Quadruplet Regimen for Newly Diagnosed Multiple Myeloma
2
FDA Expanded Approval of Imiglucerase Expands Treatment Options for Type 3 Gaucher Disease
3
Study Finds No Evidence That Hormone Therapy Use Affects Dementia Risk in Postmenopausal Women
4
FDA Draft Guidance Signals Shift Toward MRD, Complete Response as Accelerated Approval End Points in Multiple Myeloma
5